Rabies vaccine(Human diploid vell) (Beijing Minhai Biotechnology)

狂犬病疫苗(人二倍体细胞)（北京民海生物）

Report date: 2025/12/23 14:29:29

Base Information

Drug NameRabies vaccine(Human diploid vell) (Beijing Minhai Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRabies
Global Approved IndicationsRabies
Approved Indications in ChinaRabies
Original Approved Country/TerritoryMainland China
Original Approved Date2023/09/12
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsRabies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A